Starpharma Holdings Ltd (SPHRF)
0.0774
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Starpharma Holdings Price to Book Value: 1.359 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.359 |
| May 02, 2024 | 1.359 |
| May 01, 2024 | 1.359 |
| April 30, 2024 | 1.359 |
| April 29, 2024 | 1.359 |
| April 26, 2024 | 1.359 |
| April 25, 2024 | 1.740 |
| April 24, 2024 | 1.740 |
| April 23, 2024 | 1.740 |
| April 22, 2024 | 1.740 |
| April 19, 2024 | 1.740 |
| April 18, 2024 | 1.740 |
| April 17, 2024 | 1.740 |
| April 16, 2024 | 1.740 |
| April 15, 2024 | 1.740 |
| April 12, 2024 | 1.740 |
| April 11, 2024 | 1.740 |
| April 10, 2024 | 1.740 |
| April 09, 2024 | 1.820 |
| April 08, 2024 | 1.820 |
| April 05, 2024 | 1.541 |
| April 04, 2024 | 1.541 |
| April 03, 2024 | 1.541 |
| April 02, 2024 | 1.541 |
| April 01, 2024 | 1.541 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.541 |
| March 27, 2024 | 1.541 |
| March 26, 2024 | 1.541 |
| March 25, 2024 | 1.541 |
| March 22, 2024 | 1.541 |
| March 21, 2024 | 1.541 |
| March 20, 2024 | 1.541 |
| March 19, 2024 | 1.541 |
| March 18, 2024 | 1.541 |
| March 15, 2024 | 1.541 |
| March 14, 2024 | 1.541 |
| March 13, 2024 | 1.541 |
| March 12, 2024 | 1.541 |
| March 11, 2024 | 1.541 |
| March 08, 2024 | 1.541 |
| March 07, 2024 | 1.541 |
| March 06, 2024 | 1.541 |
| March 05, 2024 | 1.541 |
| March 04, 2024 | 1.541 |
| March 01, 2024 | 1.541 |
| February 29, 2024 | 1.541 |
| February 28, 2024 | 1.541 |
| February 27, 2024 | 1.541 |
| February 26, 2024 | 1.541 |
| February 23, 2024 | 1.541 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.359
Minimum
Apr 26 2024
23.39
Maximum
Dec 29 2020
7.948
Average
7.705
Median
Feb 03 2022
Price to Book Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 2.086 |
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Mesoblast Ltd | -- |
Price to Book Value Related Metrics
| PS Ratio | 5.359 |
| Price | 0.0774 |
| Earnings Yield | -19.10% |
| Market Cap | 31.89M |